AP

AVANTECA Partners

Europe, Basel-Stadt, Switzerland, Basel

Description

AVANTECA Partners is an asset management company investing in early-stage Life Science companies.

Investor Profile

AVANTECA Partners has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Switzerland, Spain.
  • Strong thematic focus on Biotechnology, Health Care, Oncology.

Stage Focus

  • Seed (83%)
  • Series Unknown (17%)

Country Focus

  • Switzerland (67%)
  • Spain (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Oncology
  • Public Safety
  • Security
  • Nanotechnology
  • Pharmaceutical
  • Medical Device
  • Health Diagnostics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AVANTECA Partners frequently co-invest with?

Co-Investments: 1
SS
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
IAG Capital Partners
North America, South Carolina, United States, Charleston
Co-Investments: 1
H. Hentsch Asset Management
Europe, Vaud, Switzerland, Nyon
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 1
OCCIDENT
Europe, Bayern, Germany, Munich
Co-Investments: 1
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 1
NC
Europe, Madrid, Spain, Madrid
Co-Investments: 1
GG
Europe, Zug, Switzerland, Cham
Co-Investments: 1

What are some of recent deals done by AVANTECA Partners?

Nanoligent

Barcelona, Catalonia, Spain

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

BiotechnologyNanotechnologyOncologyPharmaceutical
Series AOct 6, 2025
Amount Raised: $14,058,304
Onena Medicines

Donostia-san Sebastián, Pais Vasco, Spain

Onena Medicines is a biotechnology company provides medical devices, antibodies to treat cancer and rare diseases.

BiotechnologyHealth CareMedical Device
Series UnknownOct 31, 2023
Amount Raised: $4,065,599
Bearmind

Lausanne, Vaud, Switzerland

Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.

Public SafetySecurity
SeedJul 18, 2023
Amount Raised: $816,059
Bearmind

Lausanne, Vaud, Switzerland

Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.

Public SafetySecurity
SeedMar 7, 2023
Amount Raised: $1,379,571
Invasight

Zürich, Zurich, Switzerland

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

BiopharmaBiotechnologyHealth Care
SeedJun 7, 2022
Amount Raised: $4,621,931
Nanoligent

Barcelona, Catalonia, Spain

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

BiotechnologyNanotechnologyOncologyPharmaceutical
SeedFeb 3, 2022
Amount Raised: $1,143,555
Oncobit

Zürich, Zurich, Switzerland

Oncobit enabling personalized cancer care by developing precise and highly sensitive diagnostic and monitoring tests.

BiotechnologyHealth CareHealth DiagnosticsOncology
SeedApr 30, 2021
Amount Raised: $2,519,695